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Abstract
Background: Fragmented QRS (fQRS) has been shown to be a marker of local myocardial 
conduction  abnormalities  and  a  predictor  of  cardiac  events  in  selected  populations.  We 
hypothesized that the presence of a fQRS might predict arrhythmic events in patients who 
received  an implantable  cardioverter-defibrillator  (ICD),  regardless  of  the  indications  for 
implantation.  
Methods and Results: A cohort of 107 consecutive patients (mean age, 53 years; 82% male) 
who underwent an ICD implantation was studied. We defined fQRS, on a routine 12-lead 
ECG, as the presence of an additional R wave or notching in the nadir of the S wave in 2 
consecutive  leads  corresponding to  a  major  coronary  artery  territory.  In  the  presence  of 
bundle branch block, more than 2 notches in the R or S waves in 2 consecutive leads were 
required to characterize fQRS. Patients were followed for 21.3±23 months for appropriate 
ICD therapy (antitachycardia pacing and/or shock). ICDs were implanted predominantly in 
patients  with  ischemic  cardiomyopathy  (N=45,  42.1%),  followed  by  Brugada  syndrome 
(N=26,  24.3%).  fQRS presented  in  42 patients  (39.3%).  During follow-up,  patients  with 
fQRS received more appropriate ICD therapy than those without fQRS (45.2% vs. 10.8%, 
P<0.0001).  After  adjustment  for  covariates,  fQRS remained an independent  predictor  for 
appropriate  ICD  therapy  (hazard  ratio=5.32,  95%  confidence  interval=2.11-13.37, 
P<0.0001).
Conclusion: The presence of fQRS appeared to be directly associated with appropriate ICD 
therapy.
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Introduction
Implantable cardioverter-defibrillator (ICD) is by far the most effective therapy for sudden 
cardiac  arrest.  According  to  the  current  guidelines  [1,2],  the  indications  for  ICDs  are 
primarily  based  on  a  previous  history  of  sudden  cardiac  arrest  or  sustained  ventricular 
arrhythmias, certain ECGs features, New York Heart Association (NYHA) class, and left 
ventricular  ejection  fraction  (LVEF).  In  spite  of  using  these  well-established  criteria,  a 
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significant number of patients with implanted ICDs have never been treated by their ICDs 
[3,4]. Several tests have been introduced to further stratify the perfect candidates for ICDs. 
However, most of these tests provide few incremental benefits over the current criteria [5,6].
Recently, fragmented QRS (fQRS), the presence of fragmentations in the QRS complex on a 
standard 12-lead ECG, has been shown to be a predictor of mortality and sudden cardiac 
death [7]. fQRS represents inhomogeneous myocardium and local conduction abnormalities 
[8,9]. In patients with CAD, fQRS was associated with a prior myocardial scarring [10]. In 
patients  with  Brugada  syndrome  [9],  long  QT  syndrome  [11],  and  non-ischemic 
cardiomyopathy [12], fQRS was shown to predict arrhythmic events.                       
In this study, we proposed the potential role of fQRS as a risk stratifier for sudden cardiac 
arrest. We hypothesized that in patients implanted with ICDs for all indications, the presence 
of  fQRS  would  be  associated  with  a  higher  incidence  of  appropriate  ICD  therapy.
Methods
A total of 138 consecutive patients who underwent ICD implantation in our institution were 
identified.  Data  from  medical  records  during  initial  implantation  and  follow-up  were 
collected. Out of 138 patients, 31 patients were lost during follow-up and were excluded. 
Therefore, 107 patients remained in the study. All implantations were performed as indicated 
by  standard  guidelines.  The  parameters  for  ICD  detection  and  therapy  were  set  at  the 
implanters' discretion. The primary endpoint was appropriate ICD therapy, which is defined 
for  therapy  for  ventricular  arrhythmia  by  either  shock  or  antitachycardia  pacing  (ATP).
Fragmented  QRS  (fQRS)                                       
We determined the presence of fQRS by using a standard 12-lead ECG (filter range 0.15–
100 Hz;  AC filter  50  Hz,  25  mm/s,  10  mm/mV)  obtained  within  6 months  of  the  ICD 
implantation. According to previous studies [7,9-12], fQRS was defined as the presence of an 
additional  R  wave  or  notching  in  the  nadir  of  the  S  wave  in  2  consecutive  leads 
corresponding to a major  coronary artery territory (Figure 1).  In the presence of bundle 
branch block, more than 2 notches in the R or S waves in 2 consecutive leads were required 
to characterize fQRS. All ECGs were reviewed by 2 independent readers without knowledge 
of the patients. There was 99.1% concordance in the interpretation of fQRS. 
Figure 1. Example of patients with fragmented QRS. A: ECG from a 32-year-old woman with arrhythmogenic 
right ventricular dysplasia who later received multiple shocks from implantable cardioverter-defibrillator (ICD) 
due to ventricular fibrillation. B: ECG from a 36-year-old man with non-ischemic cardiomyopathy who later 
received multiple ICD therapies due to ventricular tachycardia. Fragmentations in QRS complexes are noted  
with  arrows.                                         
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Statistical  Analysis                                         
The  data  were  expressed  as  the  mean  ±  SD  values  for  continuous  variables  and  as 
frequencies for categorical variables. Comparisons of 2 groups were made with Student's t 
test for continuous variables and Pearson's chi-square test for categorical variables. Survival 
and event rates  were determined using the Kaplan-Meier method and compared between 
groups with a 2-sample log-rank test. To identify the independent predictors of the primary 
endpoint, a Cox proportional hazard model was developed. Age, sex, and the variables that 
had a P value of <0.1 by univariate analysis were entered into the model. The odd ratios 
(OR)  and  95%  confidence  intervals  (CI)  were  calculated.  All  statistical  analyses  were 
performed with SPSS 11.0 (SPSS Inc., Chicago, IL). Significance was defined as a P value 
of ≤0.05. The authors had full access to the data and take full responsibility for its integrity. 
All authors have read and agreed to the manuscript as written.                              
Results
The population (N=107, mean age 53) was predominantly male (N=88, 82.2%). More than 
half of the patients (N=71, 66%) had an ICD implanted for secondary prevention (33 patients 
with aborted sudden cardiac arrest, 65 patients with documented ventricular arrhythmias, and 
35  patients  with  syncope  and  positive  electrophysiologic  study  for  inducible  ventricular 
arrhythmias). The most common underlying cardiac pathology was ischemic cardiomyopathy 
(N=45, 42.1%), followed by Brugada syndrome (N=26, 24.3%). fQRS was detected in 42 
patients (39.3%). The average number of leads with fQRS was 3.8 leads (range 2-8). Among 
those  with  positive  electrophysiologic  study  (N=35),  15  had  fQRS (42.9%).  Comparing 
patients with and without fQRS, all had essentially the same demographics, medical history, 
LVEF, QRS duration, and QT duration (Table 1).
Table 1. Characteristics of patients with fQRS and without fQRS. 
fQRS = fragmented QRS, fQRS (+) = presence of fQRS, fQRS (-) = absence of fQRS, ICD = implantable 
cardioverter-defibrillator,  LVEF =  left  ventricular  ejection  fraction                                    
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Events
After a mean follow-up period of 21.2 months, 9 patients (8.4%) died; 8 died due to cardiac 
cause. The primary endpoint was reached in 26 patients (24.3%); 20 received ICD shock, 11 
received ATP, and 5 received both. Of those who received appropriate ICD therapy, 8 had 
ischemic cardiomyopathy, 7 had Brugada syndrome, 5 had arrhythmogenic right ventricular 
dysplasia, 4 had non-ischemic cardiomyopathy, and 2 had long QT syndrome. The incidence 
of appropriate  ICD therapy was significantly  higher in  patients  with fQRS than in those 
without fQRS (45.2% vs. 10.8%, P<0.0001,  Table 2). The incidence of fQRS, sensitivity, 
specificity,  positive  predictive  value  (PPV),  and  negative  predictive  value  (NPV)  for 
appropriate ICD therapy in various subgroups were calculated (Table 3). Except for those 
with wide QRS, the predictive accuracy were relatively the same across the subgroups.
Table 2. fQRS and incidence of ICD therapy 
fQRS = fragmented QRS, fQRS (+) = presence of fQRS, fQRS (-) = absence of fQRS, ICD = implantable 
cardioverter-defibrillator,  ATP  =  antitachycardia  pacing                               
Table 3. Incidence and predictive accuracy of fQRS for appropriate ICD therapy in various 
population
fQRS = fragmented QRS, ICD = implantable cardioverter-defibrillator, PPV = positive predictive value, NPV = 
negative  predictive  value                                              
*Cardiomyopathy  =  ischemic  cardiomyopathy,  non-ischemic  cardiomyopathy,  and  arrhythmogenic  right 
ventricular dysplasia; inherited arrhythmic syndrome = Brugada syndrome, hypertrophic cardiomyopathy, long 
QT syndrome, short  QT syndrome, and primary ventricular  fibrillation.                                   
At the 2-year mark, 94.9% of patients without fQRS were free of appropriate ICD therapy, 
compared with 66.9% of patients with fQRS (P <0.0001 by log-rank test,  Figure 2). After 
adjusting for other covariates, fQRS was the strongest independent predictor of appropriate 
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ICD therapy (HR 5.318, 95% CI 2.115-13.374, Table 4), followed by Amiodarone use (HR 
3.468, 95% CI 1.254-9.595).
Figure 2.  Kaplan-Meier survival analysis for appropriate implantable cardioverter-defibrillator (ICD) therapy 
in patients  with fragmented  QRS (fQRS).  fQRS (+)  =  presence  of  fQRS, fQRS (-)  =  absence  of  fQRS.  
Table  4. Predictors  of  appropriate  ICD therapy  according  to  a  Cox proportional  hazard 
model
ICD = implantable cardioverter-defibrillator, LVEF = left ventricular ejection fraction, 
fQRS = fragmented QRS
Discussions
In  the  present  study,  we  showed  a  strong  association  between  fQRS  and  ventricular 
arrhythmic events in patients who had ICD implantation for various indications, as well as 
for  both primary and secondary prevention.  Of all  patients  in  the  study,  24.3% received 
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appropriate  ICD  therapy.  The  incidence  increased  to  45.2%  in  patients  with  fQRS. 
Independent of the patients' characteristics, the presence of fQRS was associated with more 
than 5 times the chance of receiving appropriate ICD therapy.                               
fQRS represents an underlying arrhythmogenic substrate. The distortion and fragmentation 
of QRS occurs when normally smooth myocardial activation is disrupted [13]. The cause of 
the disruption may be either structural or functional changes. In a postmortem series, more 
notches in the QRS complex were detected in an infarcted or an enlarged ventricle than in a 
normal ventricle [8]. In patients with coronary artery disease, fQRS was shown to be a better 
marker  of  prior  myocardial  infarction  than  Q  waves  [7].  In  canine  models  of  Brugada 
syndrome, fQRS resulted from functional delay in epicardial activation, which provided a 
substrate for ventricular arrhythmia [9]. Various clinical outcome studies have confirmed the 
potential  role  of  fQRS  as  a  predictor  of  ventricular  arrhythmic  events  in  patients  with 
coronary  artery  disease,  non-ischemic  cardiomyopathy,  Brugada  syndrome,  and  acquired 
long  QT  syndrome  [7,9-12].  In  a  series  of  Brugada  syndrome  patients  with  recurrent 
ventricular arrhythmias, epicardial mapping showed abnormal low voltage and fractionated 
late potentials clustering in the anterior part of right ventricular outflow tract. Ablation over 
this area was shown to prevent recurrent ventricular arrhythmias [14].                          
Our study population represents a real life population of all-coming patients undergoing ICD 
implantation.  It  also  represents  Asian  population  where  Brugada  syndrome  is  relatively 
common. The average LVEF was 43%. The predictive accuracy of fQRS in our study was 
comparable  to  others  (sensitivity  and specificity  of 73.1% and 71.6%, PPV and NPV of 
45.2% and 89.2%, respectively). Morita et al. [9] investigated the utility of fQRS in Brugada 
syndrome, and fQRS was found in 43% of the patients. The positive and negative predictive 
values of fQRS for arrhythmic events in that study were 34% and 98.5%, respectively. In 
another study of ischemic and non-ischemic cardiomyopathy, which involved patients who 
received ICD for both primary and secondary prevention, the incidence of arrhythmic events 
in patients with fQRS was 40.5%, which is 7 times higher than that in patients without fQRS 
[12]. However, in a larger but more specific population, a prospective cohort of 842 patients 
with LVEF ≤35% who received ICD for primary prevention, fQRS was not associated with a 
higher  risk of arrhythmic  mortality  [15].  Compared to predictive  accuracy of  other  non-
invasive risk stratification tests, fQRS appears to be slightly more positively predictive but 
less negatively predictive for arrhythmic events than other tests. One meta-analysis of 19 
studies on microvolt T-wave alternans estimates the PPV and NPV for arrhythmic events at 
19.3% and 97.2%, respectively [16]. Another meta-analysis of 44 studies on signal-averaged 
ECG and heart rate variability estimated the PPV for life-threatening arrhythmic events in 
the range of 20-26%, and the NPV in the range of 95-96% [17].                            
We also  showed the  predictive  accuracy  of  fQRS in various  population.  The sensitivity 
ranged from 66-100%, and the specificity ranged from 68-89%. Of particular interest, fQRS 
was 100% sensitive in patients with QRS duration of >120 ms. Wide QRS alone has been 
shown to be a predictor of arrhythmic event [12]. fQRS in wide QRS, however, has been 
excluded by most of the studies on fQRS.  Das et al.  analyzed the cardiac events rate in 
patients with fQRS and included those with wide QRS [7]. Both fQRS and QRS duration 
were shown to be independent predictors to major cardiac events. But the influence of QRS 
duration in predictive accuracy of fQRS was not calculated in that trial. This finding might 
be  explained  by  the  electrophysiologic  property  of  amiodarone  that  delays  the  action 
potential duration which may enhance the manifestation of fQRS.                               
The limitations  of our study include the small  size of the study population and the bias 
associated with retrospective study. The utility of fQRS by itself is also limited by the lack of 
data regarding fQRS in a normal population. It remains unclear whether fQRS would have 
any prognostic  value  among patients  without  cardiac  diseases.                         
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Conclusions
We demonstrated that fQRS, as detected by standard 12-leads ECG, was a prognostic marker 
for arrhythmic events in patients implanted with ICD, regardless of the indication.  Large 
clinical trials are required to further evaluate the role of fQRS in patient selection for ICD 
implantation.  
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